Skip to main content

Dr. Goldman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Goldman's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1993 - 1996
  • Children's National Medical Center
    Children's National Medical CenterResidency, Pediatrics, 1990 - 1993
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1990

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1996 - Present
  • TX State Medical License
    TX State Medical License 1998 - 2024
  • MD State Medical License
    MD State Medical License 1993 - 1996
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Overall Survival of Children and Adolescents with Mature B Cell Non‐Hodgkin Lymphoma Who Had Refractory or Relapsed Disease During or After Treatment with FAB/LMB 96: ...  
    Mitchell Cairo, Sherrie L Perkins, Stanton Goldman, British Journal of Haematology

Abstracts/Posters

  • Polatuzumab Vedotin, an Antibody-Drug Conjugate Targeting CD79b, Is a Highly Active Agent Against Burkitt Lymphoma and Primary Mediastinal B-Cell Lymphoma
    Stanton Goldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Hospital Affiliations